FM
DXCM icon

Freemont Management’s DexCom DXCM Stock Holding History

Freemont Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-17,800
Closed -$1.18M – 140
2025
Q4 		$1.18M Buy
17,800
+11,800
+197% +$763K 0.21% 97
2025
Q3 		$404K Buy
+6,000
New +$475K 0.2% 77
2024
Q2 		– Sell
-76,300
Closed -$10.6M – 82
2024
Q1 		$10.6M Sell
76,300
-23,700
-24% -$2.98M 1.51% 21
2023
Q4 		$12.4M Sell
100,000
-124,200
-55% -$12.7M 1.56% 22
2023
Q3 		$20.9M Buy
224,200
+93,200
+71% +$10.5M 3.12% 6
2023
Q2 		$16.8M Hold
131,000
– – 2.03% 14
2023
Q1 		$15.2M Hold
131,000
– – 2.14% 11
2022
Q4 		$14.8M Buy
+131,000
New +$14.4M 2.33% 10

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Freemont Management's DXCM Position: Q1 2026 in Review

Freemont Management sold out of DexCom (DXCM) in Q1 2026, closing a stake of 17,800 shares — an estimated $1.18M sold.

Freemont Management first reported a position in DXCM in Q4 2022 and held it in 8 quarters. The position peaked at $20.9M in Q3 2023. 960 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Freemont Management reported no remaining DexCom position as of Q1 2026 after selling out during the quarter.
  • Freemont Management sold 17,800 DexCom shares in Q1 2026, an estimated $1.18M.
  • Freemont Management first reported a position in DexCom in Q4 2022 and held it in 8 quarters.
  • Freemont Management's DexCom position peaked at $20.9M in Q3 2023.
  • 960 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Freemont Management's 13F filing for Q1 2026, filed 6 May 2026.